Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Docetaxel and Prednisone (CRPC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01234025
Recruitment Status : Unknown
Verified November 2012 by Ionis Pharmaceuticals, Inc..
Recruitment status was:  Active, not recruiting
First Posted : November 4, 2010
Last Update Posted : November 5, 2012
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : September 2013
  Estimated Study Completion Date : March 2015